Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex.
about
Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity.Dysregulation and restoration of translational homeostasis in fragile X syndromeNINDS epilepsy and autism spectrum disorders workshop reportNeuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1Both maternal and pup genotype influence ultrasonic vocalizations and early developmental milestones in tsc2 (+/-) mice.Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL/6 miceThe differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex.Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions.Development of allosteric modulators of GPCRs for treatment of CNS disordersNeural connectivity abnormalities in autism: insights from the Tuberous Sclerosis model.Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities.Autism Linked to Increased Oncogene Mutations but Decreased Cancer Rate.Brain size is controlled by the mammalian target of rapamycin (mTOR) in miceGraded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features.Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complexAutistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice.Altered Structural Brain Networks in Tuberous Sclerosis ComplexImpaired language pathways in tuberous sclerosis complex patients with autism spectrum disordersA magnetic resonance imaging study of cerebellar volume in tuberous sclerosis complex.Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis.Excitatory/inhibitory imbalance in autism spectrum disorders: Implications for interventions and therapeutics.Genetic and Pharmacological Reversibility of Phenotypes in Mouse Models of Autism Spectrum Disorder.Searching for convergent pathways in autism spectrum disorders: insights from human brain transcriptome studies.Genetic control of postnatal human brain growth.Complex Neurological Phenotype in Mutant Mice Lacking Tsc2 in Excitatory Neurons of the Developing Forebrain(123).Neuronal CTGF/CCN2 negatively regulates myelination in a mouse model of tuberous sclerosis complex.Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function.Defining the role of cerebellar Purkinje cells in autism spectrum disordersTranslating genetic and preclinical findings into autism therapies.Synaptic DisordersTSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study
P2860
Q21245286-B2A83A0F-0830-4F12-9633-F0D8BDE22A76Q26782616-17166E47-97BF-4CCF-9F9B-4D9B64D35F79Q27022529-DCC09084-145A-474B-A2FA-6A3482C376ACQ28575722-ECF56849-A23D-4D3D-A5D1-22596E136E40Q30432308-80A0AD55-E84F-438F-A43C-31487D3BE1BDQ30444988-FD2C7A33-1884-41B3-9D90-A6DD880DA690Q30518266-B17C43D3-F002-4A23-99C2-43356867185AQ30747071-B962C6E6-BBC1-4754-A007-D419A19160F8Q34373958-86A08EEA-17F0-4FD4-B1A3-8B58AE3ECF9AQ34601648-4635C1EA-2451-4309-971D-16EC0F3F3022Q35765423-C341307D-3874-4994-8991-68739A7C0F35Q35943062-DC2CDD6E-8197-42DD-9A59-AF9B23B75E3CQ36124401-84A6283C-3B02-4BB1-B141-188313F11F84Q36231691-24674BA5-A0CD-4A98-850C-3D59C1F4D6B2Q36731382-8D92291A-C929-4B25-A531-26B45E898DEDQ36737172-ACD46D4E-3C8E-44B8-8B62-5007F9A5A7EEQ36794363-D36704D7-611D-4D46-B7D4-2CEF6B52893EQ36904276-4C937915-95B7-4947-BEAF-7E729A30375BQ37148933-7DBD810A-1F00-47C0-A2B6-DF3A93949770Q37613392-5EAF062E-BECB-4A87-A200-D97358650DBFQ38607739-1D4161CE-8AA2-4618-AAB3-79CE782D342DQ38678066-C2676C7F-DDA4-47A8-8471-2491AACA23E4Q38894128-6CCDA1A5-CF60-4A28-B8A1-7233B06BA136Q39023653-628DEAD7-C6DA-4D0F-ACDC-090BDCF3BBD6Q40182298-C01D2BE5-162B-4F2E-AA9A-F0781525C8D7Q41896172-86A39C68-A8A1-45B7-8C61-7538F6806900Q42049245-FC4E0E78-4142-4738-A41A-D546019BB08BQ42078036-527A8860-A6C6-4E4B-A8E0-78A90FB80708Q49337186-73C0B549-E3FF-4797-9E36-4C26FB92595BQ57267880-88378DE4-2C7E-44A0-BB41-6F368F37FF21Q58755156-4CC7FCB2-C722-41F7-B8EF-9EFD88F4C64E
P2860
Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@en
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@nl
type
label
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@en
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@nl
prefLabel
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@en
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@nl
P2860
P1476
Mechanisms of neurocognitive d ...... in tuberous sclerosis complex.
@en
P2093
Peter Tsai
P2860
P304
P356
10.1097/WCO.0B013E32834451C4
P577
2011-04-01T00:00:00Z